Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
IVMED-80 by Glaukos for Keratoconus: Likelihood of Approval
IVMED-80 is under clinical development by Glaukos and currently in Phase III for Keratoconus. According to GlobalData, Phase III drugs...